Skip to content

Health care coverage: biosimilar drugs.

It became law on Oct 8, 2023.

CA SB 621 · Senate Bill · 2023–2024

Stage
Became law
Started in
Senate
Sponsor
1
Latest action
Oct 8, 2023

What it does

Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care. Existing law provides for the regulation of health insurers by the Department of Insurance. Existing law authorizes a health care service plan or health insurer that provides coverage for prescription drugs to require step therapy if there is more than one drug that is clinically appropriate for the treatment of a medical condition, but requires a plan or insurer to expeditiously grant a step therapy exception request if specified criteria are met. Existing law does not prohibit a plan, insurer, or utilization…

Read the full text

Where it stands

This bill passed and is now law.

  1. Introduced (Done)

  2. Committee (Done)

  3. Floor (Done)

  4. Law (Done)

    Oct 8, 2023

What moved

Loading recorded actions…

Who is involved

Sponsors

The lawmakers who put their names on it, lead sponsors first.

In the news

Reporting that may mention this subject. Possible matches are labeled.

Loading coverage…

Where it goes next

Once a bill is decided, the questions are about what is done with it in California.

Work with this bill

Health care coverage: biosimilar drugs. | 52